{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:24:03Z","timestamp":1772648643964,"version":"3.50.1"},"posted":{"date-parts":[[2026,3,1]]},"group-title":"Microbiology","reference-count":54,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"name":"Oeiras Municipality and ITQB-NOVA","award":["Innovalley Proof-of-concept award 2nd and 3rd Editions"],"award-info":[{"award-number":["Innovalley Proof-of-concept award 2nd and 3rd Editions"]}]},{"name":"FCT Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia, I.P.","award":["UID\/PRR\/4612\/2025"],"award-info":[{"award-number":["UID\/PRR\/4612\/2025"]}]},{"name":"LS4FUTURE Associated Laboratory","award":["DOI 10.54499\/LA\/P\/0087\/2020"],"award-info":[{"award-number":["DOI 10.54499\/LA\/P\/0087\/2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Multidrug-resistant (MDR)\n                  <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                  , classified by the World Health Organization (WHO) as a critical priority pathogen, represents a global health thereat requiring novel antimicrobials urgently. Here we evaluated the\n                  <jats:italic>in vitro<\/jats:italic>\n                  antimicrobial activity of a novel iridium-based compound (OMKP-3), against MDR\n                  <jats:italic>K. pneumoniae<\/jats:italic>\n                  . OMKP-3 exhibited robust antimicrobial activity in M9 minimal media (MIC=6.25\u00b5g\/mL) and rapid bactericidal effect (MBC=12.5\u00b5g\/mL) against the tested MDR\n                  <jats:italic>K. pneumoniae<\/jats:italic>\n                  strains. OMKP-3 showed antibiofilm ability and was active against multiple MDR Gram-negative pathogens, including\n                  <jats:italic>Escherichia coli<\/jats:italic>\n                  ,\n                  <jats:italic>Enterobacter cloacae<\/jats:italic>\n                  ,\n                  <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                  and\n                  <jats:italic>Serratia marcescens<\/jats:italic>\n                  (MIC range:6.25-25\u00b5g\/mL). Importantly, OMKP-3 showed no cytotoxicity against mammalian cells after 24 hours of exposure. When combined with polymyxin B, OMKP-3 acted as an adjuvant, enhancing polymyxin B activity (FIC\u22640.5). OMKP-3 was less prone to induce high-level resistance in MDR\n                  <jats:italic>K. pneumoniae<\/jats:italic>\n                  compared to ciprofloxacin, and supressed the growth of resistant bacteria at a low and non-cytotoxic concentration (4xMIC).\n                  <jats:italic>K. pneumoniae<\/jats:italic>\n                  strains harboring truncated Ompk35\/36 porin genes exhibited higher OMKP-3 MICs, indicating that these porins may serve as an important entry pathway. Spectrometry analysis revealed that OMKP-3 was able to accumulate intracellularly (1.57\u00b5g\/mL), with minimal Resistance-Nodulation-Division (RND) efflux pump extrusion involvement. Furthermore, analysis of the resistant mutant, harboring a mutation in the outer membrane protein DegS, together with fluorescence microscopy, suggests that OMKP-3 induces membrane-associated damage. No cross-resistance between OMKP-3 and commonly used antibiotics was observed. Collectively, these findings identify OMKP-3 as a promising novel antimicrobial agent against MDR\n                  <jats:italic>K. pneumoniae<\/jats:italic>\n                  , likely acting through an unexplored bacterial target.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Importance<\/jats:title>\n                  <jats:p>\n                    Multidrug-resistant (MDR)\n                    <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                    is a critical global health threat and is among the leading causes of hospital0hyphenorendash;associated mortality, largely due to the scarcity of effective therapeutic options. Alarmingly, the current antimicrobial pipeline fails to address this issue, relying largely on derivatives of existing scaffolds that offer only short-term clinical benefit due to rapid resistance emergence. Developing antibiotics against Gram-negative pathogens is particularly challenging because of their highly impermeable outer membrane and efficient efflux systems, limiting intracellular drug accumulation. Metal-based antimicrobials emerge as a promising alternative. Our findings showed that OMKP-3, an iridium complex, exhibits potent bactericidal activity against MDR\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    without selecting for high-level resistance, suggesting the potential for sustained therapeutic efficacy. Additionally, it demonstrated to accumulate intracellularly with minimal efflux involvement. Together, these features position OMKP-3 as a valuable and underexplored novel antimicrobial strategy for addressing the escalating threat of MDR\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    infections.\n                  <\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.02.27.708516","type":"posted-content","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T03:25:12Z","timestamp":1772421912000},"source":"Crossref","is-referenced-by-count":0,"title":["<i>In Vitro<\/i>\n                  Activity of a Novel Metal-Based Antimicrobial against Multidrug-Resistant\n                  <i>Klebsiella pneumoniae<\/i>"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1163-5119","authenticated-orcid":false,"given":"Raquel L.","family":"Almeida","sequence":"first","affiliation":[{"name":"Laboratory of Bacterial Evolution and Molecular Epidemiology, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3762-9809","authenticated-orcid":false,"given":"Nuno A.","family":"Faria","sequence":"additional","affiliation":[{"name":"Laboratory of Bacterial Evolution and Molecular Epidemiology, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3320-868X","authenticated-orcid":false,"given":"Mariana","family":"Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Laboratory of Bacterial Evolution and Molecular Epidemiology, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3190-9351","authenticated-orcid":false,"given":"Cl\u00e1udia","family":"Malta-Lu\u00eds","sequence":"additional","affiliation":[{"name":"Yeast Molecular Biology Laboratory, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5438-8341","authenticated-orcid":false,"given":"Francisco C.","family":"Mendes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5914-5787","authenticated-orcid":false,"given":"Oscar","family":"Lenis-Rojas","sequence":"additional","affiliation":[{"name":"Organometallic Chemistry and Catalysis Group, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7909-9992","authenticated-orcid":false,"given":"Beatriz","family":"Royo","sequence":"additional","affiliation":[{"name":"Organometallic Chemistry and Catalysis Group, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1323-7184","authenticated-orcid":false,"given":"Maria","family":"Miragaia","sequence":"additional","affiliation":[{"name":"Laboratory of Bacterial Evolution and Molecular Epidemiology, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa"}]}],"member":"54368","reference":[{"key":"2026030408000656000_2026.02.27.708516v1.1","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00078-15"},{"key":"2026030408000656000_2026.02.27.708516v1.2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.4.589"},{"key":"2026030408000656000_2026.02.27.708516v1.3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)71881-X","article-title":"Hospital-acquired neonatal infections in developing countries","volume":"365","year":"2005","journal-title":"The Lancet"},{"key":"2026030408000656000_2026.02.27.708516v1.4","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13007"},{"key":"2026030408000656000_2026.02.27.708516v1.5","unstructured":"WHO Regional Office for Europe and European Centre for Disease Prevention and Control. 2025. Surveillance of antimicrobial resistance in Europe, 2024 data: executive summary. Copenhagen."},{"key":"2026030408000656000_2026.02.27.708516v1.6","unstructured":"European Centre for Disease Prevention and Control. 2025. Antimicrobial resistance in the EU\/EEA (EARS-Net ) - Annual Epidemiological Report 2024. Stockholm."},{"key":"2026030408000656000_2026.02.27.708516v1.7","unstructured":"European Centre for Disease Prevention and Control. 2023. Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual Epidemiological Report 2022. Stockholm."},{"key":"2026030408000656000_2026.02.27.708516v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70041-0"},{"key":"2026030408000656000_2026.02.27.708516v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0\/ATTACHMENT\/4504FC2B-08AE-46D6-BD75-80811DF8B5E6\/MMC1.PDF"},{"key":"2026030408000656000_2026.02.27.708516v1.10","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.0c01213"},{"key":"2026030408000656000_2026.02.27.708516v1.11","first-page":"1","article-title":"Tackling the outer membrane: facilitating compound entry into Gram-negative bacterial pathogens","volume":"1","year":"2023","journal-title":"Antimicrobials and Resistance"},{"key":"2026030408000656000_2026.02.27.708516v1.12","first-page":"1","article-title":"Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis","volume":"12","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2026030408000656000_2026.02.27.708516v1.13","unstructured":"World Health Organization. 2024. WHO Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. WHO Bacterial Priority Pathogens List."},{"key":"2026030408000656000_2026.02.27.708516v1.14","unstructured":"World Health Organization. 2024. 2023 Antibacterial agents in clinical and preclinical development: an overview and analysis. 2023 Antibacterial agents in clinical and preclinical development."},{"key":"2026030408000656000_2026.02.27.708516v1.15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41570-023-00463-4","article-title":"Metals to combat antimicrobial resistance","volume":"7","year":"2023","journal-title":"Nat Rev Chem"},{"key":"2026030408000656000_2026.02.27.708516v1.16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chempr.2019.10.013","article-title":"Classification of Metal-Based Drugs according to Their Mechanisms of Action","volume":"6","year":"2020","journal-title":"Chem"},{"key":"2026030408000656000_2026.02.27.708516v1.17","doi-asserted-by":"publisher","DOI":"10.1039\/C9SC06460E"},{"key":"2026030408000656000_2026.02.27.708516v1.18","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1002\/cctc.201700678","article-title":"Water-Soluble Iridium N-Heterocyclic Carbene Complexes for the Alkylation of Amines with Alcohols","volume":"9","year":"2017","journal-title":"ChemCatChem"},{"key":"2026030408000656000_2026.02.27.708516v1.19","doi-asserted-by":"publisher","DOI":"10.3390\/biom12030368"},{"key":"2026030408000656000_2026.02.27.708516v1.20","unstructured":"2020. ONEIDA - an omics network. https:\/\/www.itqb.unl.pt\/oneida. Retrieved 20 July 2024."},{"key":"2026030408000656000_2026.02.27.708516v1.21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054583"},{"key":"2026030408000656000_2026.02.27.708516v1.22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cell.2007.10.021","article-title":"Allosteric Activation of a Bacterial Stress Sensor","volume":"131","year":"2007","journal-title":"Cell"},{"key":"2026030408000656000_2026.02.27.708516v1.23","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-015-0426-4"},{"key":"2026030408000656000_2026.02.27.708516v1.24","doi-asserted-by":"publisher","DOI":"10.3390\/biom12030368"},{"key":"2026030408000656000_2026.02.27.708516v1.25","unstructured":"UCSF Health. 2023. Plasma amino acids. https:\/\/www.ucsfhealth.org\/medical-tests\/plasma-amino-acids. Retrieved 26 January 2026."},{"key":"2026030408000656000_2026.02.27.708516v1.26","first-page":"1","article-title":"Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses","volume":"15","year":"2024","journal-title":"Antimicrobial Chemotherapy"},{"key":"2026030408000656000_2026.02.27.708516v1.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84191-9"},{"key":"2026030408000656000_2026.02.27.708516v1.28","doi-asserted-by":"crossref","unstructured":"Hackel MA , Tsuji M , Yamano Y , Echols R , Karlowsky JA , Sahm DF . 2018. In vitro activity of the siderophore cephalosporin, cefiderocol, against carbapenem-nonsusceptible and multidrug-resistant isolates of gram-negative bacilli collected worldwide in 2014 to 2016. Antimicrob Agents Chemother 62.","DOI":"10.1128\/AAC.01968-17"},{"key":"2026030408000656000_2026.02.27.708516v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00443-1"},{"key":"2026030408000656000_2026.02.27.708516v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.06.049"},{"key":"2026030408000656000_2026.02.27.708516v1.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.02.014"},{"key":"2026030408000656000_2026.02.27.708516v1.32","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/jm900999h","article-title":"Structure - Activity Relationships of Polymyxin Antibiotics","volume":"53","year":"2010","journal-title":"Journal of Medical Chemistry"},{"key":"2026030408000656000_2026.02.27.708516v1.33","first-page":"607","article-title":"Synergistic combinations of polymyxins","volume":"6","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"2026030408000656000_2026.02.27.708516v1.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.03.007"},{"key":"2026030408000656000_2026.02.27.708516v1.35","doi-asserted-by":"publisher","DOI":"10.1038\/nature22308"},{"key":"2026030408000656000_2026.02.27.708516v1.36","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.0c00895"},{"key":"2026030408000656000_2026.02.27.708516v1.37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005361"},{"key":"2026030408000656000_2026.02.27.708516v1.38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jhin.2024.02.028","article-title":"Genomic insights into the expansion of carbapenem-resistant Klebsiella pneumoniae within Portuguese hospitals","volume":"148","year":"2024","journal-title":"Journal of Hospital Infection"},{"key":"2026030408000656000_2026.02.27.708516v1.39","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2024. Broth microdilution \u2013 EUCAST reading guide v.5.0."},{"key":"2026030408000656000_2026.02.27.708516v1.40","unstructured":"Clinical and Laboratory Standards Institute. 1999. M26-A Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline."},{"key":"2026030408000656000_2026.02.27.708516v1.41","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12651"},{"key":"2026030408000656000_2026.02.27.708516v1.42","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00088-15"},{"key":"2026030408000656000_2026.02.27.708516v1.43","doi-asserted-by":"crossref","unstructured":"Kwasny SM , Opperman TJ . 2010. Static Biofilm Cultures of Gram-Positive Pathogens Grown in a Microtiter Format Used for Anti-Biofilm Drug Discovery. Curr Protoc Pharmacol 1\u201323.","DOI":"10.1002\/0471141755.ph13a08s50"},{"key":"2026030408000656000_2026.02.27.708516v1.44","doi-asserted-by":"crossref","unstructured":"Christensen GD , Simpson WA , Anglen JO , Gainorl BJ . 2000. Handbook of bacterial adhesion: Methods for Evaluating Attached Bacteria and Biofilms1\u00b0. Springer Nature.","DOI":"10.1007\/978-1-59259-224-1_13"},{"key":"2026030408000656000_2026.02.27.708516v1.45","first-page":"1","article-title":"New and simplified method for drug combination studies by checkerboard assay","volume":"8","year":"2021","journal-title":"MethodsX"},{"key":"2026030408000656000_2026.02.27.708516v1.46","doi-asserted-by":"crossref","unstructured":"Ghasemi M , Turnbull T , Sebastian S , Kempson I . 2021. The MTT assay: Utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis. Int J Mol Sci 22.","DOI":"10.3390\/ijms222312827"},{"key":"2026030408000656000_2026.02.27.708516v1.47","unstructured":"International Standard. 2009. ISO 10993-5 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity. ISO 10993-5."},{"key":"2026030408000656000_2026.02.27.708516v1.48","doi-asserted-by":"crossref","first-page":"9653","DOI":"10.1039\/D2DT00752E","article-title":"Inert cationic iridium(III) complexes with phenanthroline-based ligands: application in antimicrobial inactivation of multidrug-resistant bacterial strains","volume":"51","year":"2022","journal-title":"Dalton Transactions"},{"key":"2026030408000656000_2026.02.27.708516v1.49","unstructured":"Disk E , Method D , Susceptibility A , Version T . 2025. Antimicrobial susceptibility testing: EUCAST disk diffusion method. European Journal of Clinical Microbiology & Infectious Diseases version 13."},{"key":"2026030408000656000_2026.02.27.708516v1.50","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2024. Breakpoint tables for interpretation of MICs and zone diameters Version 14.0."},{"key":"2026030408000656000_2026.02.27.708516v1.51","unstructured":"MP Machado , J Halkilahti , A Jaakkonen , DN Silva , I Mendes , Y Nalbantoglu , V Borges , M Ramirez , M Rossi , JA Carri\u00e7o . INNUca Github. https:\/\/github.com\/B-UMMI\/INNUca. Retrieved 10 May 2024."},{"key":"2026030408000656000_2026.02.27.708516v1.52","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu153"},{"key":"2026030408000656000_2026.02.27.708516v1.53","unstructured":"Seemann T. 2015. Snippy: fast bacterial variant calling from NGS reads. https:\/\/github.com\/tseemann\/snippy."},{"key":"2026030408000656000_2026.02.27.708516v1.54","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/nar\/gkaf394","article-title":"The UniProt websit API : facilitating programmatic access to protein knowledge","volume":"53","author":"the UniProt Consortium","year":"2025","journal-title":"Nucleic Acids Res"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.02.27.708516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:00:15Z","timestamp":1772640015000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.02.27.708516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":54,"URL":"https:\/\/doi.org\/10.64898\/2026.02.27.708516","relation":{},"subject":[],"published":{"date-parts":[[2026,3,1]]},"subtype":"preprint"}}